INSM Sara Bonstein sells $5.9M worth of shares
Jun 26, 2025, 4:35 AM
0.00%
What does INSM do
Insmed is a biopharmaceutical company based in Bridgewater, New Jersey, focusing on therapies for rare diseases, employing 912 staff. Its key products include ARIKAYCE, brensocatib, and TPIP for various lung diseases.
Sara Bonstein sold 57,765 shares of INSM on 23 June at $102.15 per share, worth a total of $5.9M. They now own 102,197 INSM shares, or a 38% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.